89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
8.35
+0.02 (0.24%)
At close: Jul 19, 2024, 4:00 PM
8.36
+0.01 (0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

89bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Market Capitalization
822845592265484363
Market Cap Growth
36.82%42.62%123.48%-45.28%33.64%-
Enterprise Value
287293425134280269
PE Ratio
--5.94-5.81-2.94-9.79-6.31
PB Ratio
1.611.583.902.112.394.03
P/FCF Ratio
-7.84-6.54-7.31-3.45-10.45-14.16
P/OCF Ratio
-7.84-6.54-7.31-3.45-10.48-14.24
EV/EBITDA Ratio
-3.52-2.20-4.25-1.49-5.65-4.71
EV/EBIT Ratio
-3.51-2.20-4.24-1.49-5.65-4.71
EV/FCF Ratio
-3.99-2.27-5.24-1.74-6.03-10.51
Debt / Equity Ratio
0.050.050.140.15--
Debt / EBITDA Ratio
-0.17-0.20-0.21-0.22--
Debt / FCF Ratio
-0.20-0.21-0.25-0.25--
Quick Ratio
14.7019.557.647.7225.2316.64
Current Ratio
15.0320.047.978.2925.9117.00
Interest Coverage
-43.97-27.85-52.07-132.93--
Return on Equity (ROE)
-34.80%-31.00%-83.70%-56.70%-34.90%-155.40%
Return on Assets (ROA)
-31.00%-27.80%-59.90%-50.70%-33.10%-107.40%
Return on Capital (ROIC)
-33.46%-26.84%-59.32%-61.74%-24.32%-29.62%
Earnings Yield
-20.09%-16.83%-17.22%-34.00%-10.22%-15.84%
FCF Yield
-16.90%-15.29%-13.69%-28.99%-9.57%-7.06%
Buyback Yield / Dilution
-80.26%-104.48%-73.18%-24.93%-586.28%-428.25%
Total Shareholder Return
-80.26%-104.48%-73.18%-24.93%-586.28%-428.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).